Skip to main content
Signal8

Madden Martin J.

SEC insider (Form 3/4/5 filer). CIK 0001696864. Director at NovoCure Ltd (NVCR) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in WAYNE, PA.

Companies Madden Martin J. has filed insider reports for

  • NovoCure Ltd (NVCR): Director
  • Microbot Medical Inc. (MBOT): Director
Madden Martin J. profile photo

Madden Martin J.

CIK: 0001696864

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NovoCure Ltd logo
NVCR

NovoCure Ltd

Director
Microbot Medical Inc. logo
MBOT

Microbot Medical Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 3, 2026
    Award
    Direct
    11.6K shares-
  • Microbot Medical Inc. logo
    MBOT

    Microbot Medical Inc.

    Apr 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    10K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 4, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    33.4K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 3, 2025
    Sale
    Direct
    999 shares at avg. $17.19$17K
  • Microbot Medical Inc. logo
    MBOT

    Microbot Medical Inc.

    Jan 28, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    10K shares-

1-5 of 5